pharmacoeconomic moh program 1
TRANSCRIPT
Norah Al JohanyHead of Pharmacoeconomic department General administration of pharmaceutical [email protected]
Pharmacoeconomic PROGRAM 1
70Pharmacists
4 Pharmacists
Pharmacoeconomic Analysis of DPIC InquiriesLevel ($) Description ($) Cost 95% CI
0 No medication-related problems 0 NA
1 No change in therapy or no harm 0 NA
2 Physician visit 64.50 NA
3a Additional tests 95.00 73-116
3b Non-invasive procedure 184.00 120-248
4a Additional treatment 227.00 147-306
4b Additional treatment/ non-invasive procedure 411.00 267-554
4c Increased length of stay/ invasive procedure 2505.00 1569-3441
4d Increased length of stay 2598.00 1471-3722
5a Transfer to ICU 2640.00 1471-3808
5b Transfer to ICU/invasive procedure 5145.00 3040-7249
5c Long-term care admission 4571.47 NA
6 Death 100,000.00 NA
Example
• Dr prescribe Denosumab for my 50 y old mother I want complete drug information
• If I did not answer the question what will happen ?
• The use of dentinox for my 1 w y old doter
Total Cost Saving = 139155 $ / one month
Pharmacists intervention cost
Part 2
• Saudi Arabian healthcare budget seen to surge 74% with (4.550.000.000) billion riyals approved amount budget for medicines and medical supplies
• So we have to Respond to society’s question: “Are we receiving the greatest benefit for our health care riyals?”
• With the Growing number of alternatives Need for efficiency and Rising health care cost
Need for Pharmacoeconomic in the ministry of health
Ministry of healthKingdom of Saudi ArabiaPharmacoeconomic Manual
Formulary management • Clinical decisions – drug selection at patient level• Drug policy • MOH Program management • Resource allocation • Purchase negotiation
Decisions supported by pharmacoeconomic studies
•It is the policy of the Pharmacoeconomic center to do intensive analysis, for all new drug need to be add on the formulary and having evidence for using reported pharmacoeconomics data to improve medication use process and reduce cost rate properly
•It is the policy of the Pharmacoeconomic center to calculate Calculation the cost benefit for MOH program
Policy
•Filling the Pharmacoeconomic MOH Forms for DUE•Pharmacoeconomic Literature Evaluation •Quality of life measuring tool•Assessment tool of medication compliance and persistence)•calculation adverse drug reaction •Calculation the cost benefit for MOH program
Procedures
•To change the misunderstanding of of the Pharmacoeconomic concepts in the ministry of health (NOT DIRECT PRICE) •Cost does not equal the price of a product
Ministry of health Pharmacoeconomic Principles
Decisions makers pharmacist and healthcare provider in the MOH must understand • The Criteria for evaluating pharmaceuticals are safety +efficacy +value • Pharmacoeconomic analysis includes all costs associated with an intervention• How to use the Pharmacoeconomic tools in Decision making
Goal
•It is the policy of the Pharmacoeconomic center to provide training and service programs to enhance the application of economic and effectiveness measures to the practice of health care and the management of health systems
Policy
Part 3
•Purpose ?•How
Ministry of health Pharmacoeconomic Research
Drug Related Problems Program forms to calculate the cost of Medication Errors Adverse drug reaction
Filling Pharmacoeconomic MOH data collection forms
•DPIC Inquiries Program•Drug evaluation scoring•Pharmacist intervention cost of avoidance
Cost analysis
Part 4
•Participates in Conferences and exhibitions and forums•Subscriptions books and scientific journals and special pharmacoeconomic educational materials
Establishes Pharmacoeconomic specialist pharmacist program